SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
FDA Grants Priority Review Status to Sucampo Pharmaceuticals, Inc.'s AMITIZA® (lubiprostone) Submission Seeking Approval for Treatment of Opioid-induced Constipation